THIS
ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR
RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY
OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE
REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY JURISDICTION IN WHICH IT
WOULD BE UNLAWFUL TO DO SO.
THIS IS AN
ANNOUNCEMENT AND NOT A PROSPECTUS OR A PROSPECTUS EQUIVALENT
DOCUMENT AND INVESTORS AND PROSPECTIVE INVESTORS SHOULD NOT MAKE
ANY INVESTMENT DECISION ON THE BASIS OF ITS CONTENTS. A PROSPECTUS
IN RELATION TO THE ACQUISITION WAS PUBLISHED ON 1 JULY 2024
("ORIGINAL PROSPECTUS") WHICH WAS SUPPLEMENTED BY A SUPPLEMENTARY
PROSPECTUS DATED 3 SEPTEMBER 2024.
30 September
2024
LEI: 2549008KZ7HM27V4O637
Marwyn Acquisition Company II
Limited
(the
"Company")
Update on the acquisition of
InvestAcc
Further to the Company's announcement on 28 June
2024 that it has entered into a binding agreement to acquire 100
per cent. of the issued share capital of InvestAcc Group Limited
("InvestAcc") a leading
pensions services provider, the Company is pleased to announce that
it has received the necessary regulatory approvals from the
Financial Conduct Authority ("FCA") in respect of the change in
control of the entities in the InvestAcc Group that are FCA
authorised and will therefore proceed to Completion.
Accordingly, Completion of the Acquisition is
expected to occur on 9 October 2024 subject to the FCA agreeing to
the Re-Admission of the Enlarged Ordinary Share Capital of the
Company to the equity shares (transition) category of the Official
List and the London Stock Exchange having acknowledged that the
Enlarged Ordinary Share Capital will be admitted to trading on its
main market for listed securities, in each case with effect from
Completion.
Expected
Timetable
All times shown are London times unless
otherwise stated. All dates and times are based on the current
expectations of the Company and are subject to change. If any of
the dates and/or times in this expected timetable change, the
revised dates and/or times will be notified by announcement through
a Regulatory Information Service.
Event
|
Time and / or date
|
Expected date of Completion
|
Before 8 a.m. on 9
October 2024
|
Cancellation of the listing of the Ordinary
Shares on the London Stock Exchange
|
8 a.m. on 9 October
2024
|
Admission of the Consideration
Shares
|
8 a.m. on 9 October
2024
|
Re-Admission of the Ordinary Shares
|
8 a.m. on 9 October
2024
|
Despatch of definitive certificates in respect
of the
Consideration Shares
|
By no later than 14
days after
Re-Admission
|
Defined terms used in this announcement shall
have the meaning given in the Original Prospectus, unless otherwise
defined.
Enquiries:
Company Secretary
Antoinette Vanderpuije - 020 7004
2700
Zeus Capital Limited - Corporate Broker
- +44 (0) 207 220
1666
Harry Ansell
Katy Mitchell
Panmure Liberum Capital Limited (Financial Adviser) - 44 (0)
203 100 2000
Chris Clarke / Ed Thomas / Anake
Singh
IMPORTANT NOTICES
Neither this announcement nor any
copy of it may be taken or transmitted directly or indirectly into
or from any jurisdiction where to do so would constitute a
violation of the relevant laws or regulations of such jurisdiction.
Any failure to comply with this restriction may constitute a
violation of such laws or regulations. Persons into whose
possession this announcement or other information referred to
herein comes should inform themselves about, and observe, any
restrictions in such laws or regulations. This announcement has
been prepared for the purpose of complying with the applicable law
and regulation of the United Kingdom and information disclosed may
not be the same as that which would have been disclosed if this
announcement had been prepared in accordance with the laws and
regulations of jurisdictions outside the United Kingdom.
This announcement does not constitute
or form part of any offer, invitation to sell, otherwise dispose of
or issue, or any solicitation of any offer to purchase or subscribe
for, any shares or other securities nor shall it or any part of it,
nor the fact of its distribution form the basis of, or be relied on
in connection with, any contract commitment or investment
decision.
This announcement does not constitute
an offer of securities for sale in the United States or an offer to
acquire or exchange securities in the United States. No offer to
acquire securities or to exchange securities for other securities
has been made, or will be made, directly or indirectly, in or into,
or by use of the mails, any means or instrumentality of interstate
or foreign commerce or any facilities of a national securities
exchange of, the United States or any other country in which such
offer may not be made other than: (i) in accordance with applicable
United States securities laws or the securities laws of such other
country, as the case may be; or (ii) pursuant to an available
exemption from such requirements. The securities referred to herein
have not been and will not be registered under the U.S. Securities
Act of 1933, as amended, or under the securities laws of any state
or other jurisdiction of the United States.
Panmure Liberum Capital
("Panmure Liberum") is
authorised and regulated in the United Kingdom by the FCA and is
acting as financial adviser for the Company and no one else in
connection with the matters described in this announcement. Panmure
Liberum will not regard any other person as its client in relation
to the matters described in this announcement and will not be
responsible to anyone other than the Company for providing the
protections afforded to its clients or for providing advice to any
other person in relation to the matters referred to in this
announcement.
This announcement is not a prospectus
but an advertisement. Neither this announcement nor anything
contained in it shall form the basis of, or be relied upon in
conjunction with, any offer or commitment whatsoever in any
jurisdiction. Investors should not acquire any Ordinary Shares
referred to in this announcement except on the basis of the
information contained in the Original Prospectus and the
Supplementary Prospectus published by the Company.